Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) announced a dividend on Monday, March 10th, NASDAQ Dividends reports. Investors of record on Monday, April 7th will be given a dividend of 0.3758 per share by the biotechnology company on Wednesday, April 23rd. The ex-dividend date of this dividend is Monday, April 7th. This is a 123.9% increase from Novozymes A/S’s previous dividend of $0.17.
Novozymes A/S Stock Performance
Novozymes A/S stock traded up $0.65 on Tuesday, reaching $58.96. The company’s stock had a trading volume of 10,482 shares, compared to its average volume of 20,958. The business’s fifty day moving average price is $57.04 and its 200 day moving average price is $61.33. The company has a market cap of $27.61 billion, a price-to-earnings ratio of 37.32, a PEG ratio of 3.87 and a beta of 0.91. Novozymes A/S has a twelve month low of $52.96 and a twelve month high of $72.50.
Analyst Upgrades and Downgrades
Separately, Barclays raised shares of Novozymes A/S to a “strong-buy” rating in a report on Monday, November 18th.
Novozymes A/S Company Profile
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Further Reading
- Five stocks we like better than Novozymes A/S
- What is a Death Cross in Stocks?
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- How to invest in marijuana stocks in 7 steps
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- How Technical Indicators Can Help You Find Oversold Stocks
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.